7. Lactancia materna y fármacos antiasmáticos
7.9 MOMETASONA FUROATO
Corticoide.Mometasona furoato. Lactancia. Riesgo Poco probable que alcance concentraciones significativas en leche por su escasa absorción sistémica (< 0,1%). Su elevada unión a proteínas lo hace aún más improbable.
Nivel 0: Riesgo muy bajo. Compatible y sin riesgo para la lactancia y el lactante
- Powrie RO, Larson L, Miller M.Managing asthma in expectant mothers.Treat Respir Med. 2006;5:1–10.
- National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115:34–46.
- National Asthma Education and Prevention Program. Quick Reference from the Working Group Report on Managing asthma during pregnancy: recommendations for pharmacologic treatment. Update 2004. 2005.
- Ellsworth A. Pharmacotherapy of asthma while breastfeeding. J Hum Lact. 1994;10:39–41.
- Greenberger PA, Patterson R.The management of asthma during pregnancy and lactation. Clin Rev Allergy. 198;5:317–247.